Int J Med Sci 2008; 5(1):9-17. doi:10.7150/ijms.5.9 This issue Cite

Research Paper

Does eGFR improve the diagnostic capability of S-Creatinine concentration results? A retrospective population based study

Anders Kallner 1, Peter A Ayling 2, Zahra Khatami 2

1. Department of Clinical Chemistry, Karolinska University Hospital, SE 17176, Stockholm, Sweden
2. Department of Biochemistry, Queen's Hospital, Romford, Essex, RM70AG UK

Citation:
Kallner A, Ayling PA, Khatami Z. Does eGFR improve the diagnostic capability of S-Creatinine concentration results? A retrospective population based study. Int J Med Sci 2008; 5(1):9-17. doi:10.7150/ijms.5.9. https://www.medsci.org/v05p0009.htm
Other styles

File import instruction

Abstract

The use of MDRD-eGFR to diagnose Chronic Kidney Disease (CKD) is based on the assumption that the algorithm will minimize the influence of age, gender and ethnicity that is observed in S-Creatinine concentration and thus allow a single cut-off at which further diagnostic and therapeutic actions should be considered. This hypothesis is tested in a retrospective analysis of outpatients (N=93,404) and hospitalised (N=35,572) patients in UK and Sweden, respectively. An algorithm based on the same model as the MDRD-eGFR algorithm was derived from simultaneously measured S-Creatinine concentrations and Iohexol GFR in a subset of 565 patients. The combined uncertainty of using this algorithm was estimated to about 15 % which is about three times that of the S-Creatinine concentration results. The diagnostic performance of S-Creatinine concentration was evaluated using the Iohexol clearance as the reference procedure. It was shown that the diagnostic capacity of MDRD-eGFR, as it stands, has no added value compared to S-Creatinine. The gender and age differences of the S-Creatinine concentrations in the dataset persist after applying the MDRD-eGFR algorithm. Thus, a general use of the MDRD-eGFR does not seem justified. Furthermore the claim that the eGFR is adjusted for body area is misleading; the algorithm does not include any body size marker. It is thus a dangerous marker for guiding drug administration.

Keywords: CKD, Diagnosis, algorithm, outpatients, inpatients


Citation styles

APA
Kallner, A., Ayling, P.A., Khatami, Z. (2008). Does eGFR improve the diagnostic capability of S-Creatinine concentration results? A retrospective population based study. International Journal of Medical Sciences, 5(1), 9-17. https://doi.org/10.7150/ijms.5.9.

ACS
Kallner, A.; Ayling, P.A.; Khatami, Z. Does eGFR improve the diagnostic capability of S-Creatinine concentration results? A retrospective population based study. Int. J. Med. Sci. 2008, 5 (1), 9-17. DOI: 10.7150/ijms.5.9.

NLM
Kallner A, Ayling PA, Khatami Z. Does eGFR improve the diagnostic capability of S-Creatinine concentration results? A retrospective population based study. Int J Med Sci 2008; 5(1):9-17. doi:10.7150/ijms.5.9. https://www.medsci.org/v05p0009.htm

CSE
Kallner A, Ayling PA, Khatami Z. 2008. Does eGFR improve the diagnostic capability of S-Creatinine concentration results? A retrospective population based study. Int J Med Sci. 5(1):9-17.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image